Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.32 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.31 |
| ▸ | JUN | P05412 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27176003 | 1.00 | GABRA1 (0.46) | GABRA1SIGMAR1PTGS1PTGS2ALOX5 | |
| SCHEMBL28684322 | 0.97 | GABRA1 (0.46) | GABRA1SIGMAR1PTGS1PTGS2ALOX5 | |
| SCHEMBL5229721 | 0.97 | GABRA1 (0.46) | GABRA1SIGMAR1PTGS1PTGS2ALOX5 | |
| SCHEMBL27532389 | 0.90 | GABRA1 (0.42) | GABRA1SIGMAR1TRPA1 | |
| SCHEMBL5231365 | 0.87 | GPR183 (0.34) | GABRA1SIGMAR1PTGS1PTGS2ALOX5 | |
| SCHEMBL34956 | 0.84 | TUBB1 (0.37) | PTGS1PTGS2ALOX5TUBB1 | |
| SCHEMBL29373037 | 0.84 | TUBB1 (0.37) | PTGS1PTGS2ALOX5TUBB1 | |
| SCHEMBL5229472 | 0.84 | TRPA1 (0.41) | PTGS2NFE2L2TRPA1JUN | |
| SCHEMBL20599343 | 0.84 | TUBB1 (0.37) | PTGS1PTGS2ALOX5TUBB1 | |
| SCHEMBL7117533 | 0.81 | TUBB1 (0.37) | PTGS1PTGS2ALOX5TUBB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1313741-B1 | FLUORINATED AND ALKYLATED ALDITOL DERIVATIVES AND POLYOLEFIN ARTICLES CONTAINING SAME | MILLIKEN & CO (US) | 2007-05-23 | — | — | EP | claimed |
| EP-1409579-B1 | CLARIFYING AGENT FORMULATIONS FOR THERMOPLASTICS EXHIBITING VERY HIGH NUCLEATION EFFICACY | MILLIKEN & CO (US) | 2006-12-20 | — | — | EP | claimed |
| US-6906207-B2 | Polymer additive compositions and articles comprising novel fluorinated and alkylated alditol derivatives | MILLIKEN & COMPANY (US) | 2005-06-14 | — | — | US | claimed |
| EP-1409579-A4 | CLARIFYING AGENT FORMULATIONS FOR THERMOPLASTICS EXHIBITING VERY HIGH NUCLEATION EFFICACY | MILLIKEN & CO (US) | 2005-03-09 | — | — | EP | claimed |
| US-6849747-B2 | Fluorinated and alkylated dibenzylidene alditol derivatives | MILLIKEN & COMPANY (US) | 2005-02-01 | — | — | US | claimed |
| US-20040110967-A1 | Novel fluorinated and alkylated dibenzylidene alditol derivatives | ANDERSON JOHN D (US) | 2004-06-10 | — | — | US | claimed |
| US-6734238-B2 | RADIATION TRANSPARENT; ANTIPERSPIRANT GEL | MILLIKEN & COMPANY | 2004-05-11 | — | — | US | claimed |
| EP-1409579-A1 | CLARIFYING AGENT FORMULATIONS FOR THERMOPLASTICS EXHIBITING VERY HIGH NUCLEATION EFFICACY | Milliken & Company (US) | 2004-04-21 | — | — | EP | claimed |
| US-20030181552-A1 | Polymer additive compositions and articles comprising novel fluorinated and alkylated alditol derivatives | ANDERSON JOHN D (US) | 2003-09-25 | — | — | US | claimed |
| US-20030171462-A1 | Polyolefin compositions and articles comprising novel fluorinated and alkylated alditol derivatives | ANDERSON JOHN D (US) | 2003-09-11 | — | — | US | claimed |
| US-6585819-B2 | Polypropylene containing saturated bicyclic carboxylic acid and dibenzylidene alditol acetal derivative additives | MILLIKEN & COMPANY | 2003-07-01 | — | — | US | claimed |
| EP-1313741-A2 | FLUORINATED AND ALKYLATED ALDITOL DERIVATIVES AND POLYOLEFIN ARTICLES CONTAINING SAME | Milliken & Company (US) | 2003-05-28 | — | — | EP | claimed |
| US-20030073764-A1 | Clarified thermoplastics exhibiting very high nucleation efficacy | MILLIKEN & COMPANY | 2003-04-17 | — | — | US | claimed |
| WO-2003016421-A1 | CLARIFIED THERMOPLASTICS EXHIBITING VERY HIGH NUCLEATION EFFICACY | MILLIKEN & COMPANY (US) | 2003-02-27 | — | — | WO | claimed |
| US-6521685-B1 | Clarifying agent formulations for thermoplastics exhibiting very high nucleation efficacy | MILLIKEN & COMPANY | 2003-02-18 | — | — | US | claimed |
| WO-2003004554-A1 | CLARIFYING AGENT FORMULATIONS FOR THERMOPLASTICS EXHIBITING VERY HIGH NUCLEATION EFFICACY | MILLIKEN & COMPANY (US) | 2003-01-16 | — | — | WO | claimed |
| US-20020062034-A1 | Novel fluorinated and alkylated alditol derivatives and compositions and polyolefin articles containing same | MILLIKEN &COMPANY | 2002-05-23 | — | — | US | claimed |
| WO-2002020528-A2 | FLUORINATED AND ALKYLATED ALDITOL DERIVATIVES AND POLYOLEFIN ARTICLES CONTAINING SAME | MILLIKEN & COMPANY (US) | 2002-03-14 | — | — | WO | claimed |
| CN-114058142-B | Transparent fluorine-containing polymer film | 浙江省化工研究院有限公司 | 2023-05-12 | — | — | CN | disclosed |
| WO-2002020528-A2 | FLUORINATED AND ALKYLATED ALDITOL DERIVATIVES AND POLYOLEFIN ARTICLES CONTAINING SAME | MILLIKEN & COMPANY (US) | 2002-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110967-A1 | Novel fluorinated and alkylated dibenzylidene alditol derivatives | ALDOA, DERA, SORD | GABRA1 1531/4885SIGMAR1 2718/4885PTGS1 3793/4885 |
| US-20020062034-A1 | Novel fluorinated and alkylated alditol derivatives and compositions and polyolefin articles containing same | ALDOA, SORD, DERA | GABRA1 2039/4885SIGMAR1 1882/4885PTGS1 2679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.